Drugs A-Z Is my price fair? Price changes Drug markups Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme
Class ITerminatedD-0040-2025

Drug recall · November 13, 2024

Ascorbic Acid Inj. Solution recall

Why: Presence of Particulate Matter: Presence of glass particulates.

Class I: a reasonable chance the product could cause serious harm or death.

The recall

Product

Ascorbic Acid Inj. Solution, 25,000mg/50mL (500mg/mL), 50mL single use vial, Rx only, Staska Pharmaceuticals, 742 Evergreen Drive, Bennet, NE 68317

Lots / codes

Lot #SP2400058, Exp 12/31/2024

Quantity
4773 vials
Company
Staska Pharmaceuticals, Inc., Bennet, NE
Distribution
Nationwide in the USA
Initiated
September 30, 2024 · Voluntary: Firm initiated
Classified
November 7, 2024
Reported
November 13, 2024
Ended
August 5, 2025
How notified
Letter

The drug: prices, other makers, shortages

If you have this product

  1. Check the lot number on your package against the lots above. Only those lots are recalled.
  2. Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
  3. Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
  4. Return or dispose of recalled product as the company or your pharmacy advises.

Questions about this recall

Be kind and stay on topic. No personal health details, links or selling. This is not medical advice.

No comments yet. Questions, tips, what worked for you - start the conversation.

Watch Ascorbic acid

One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.